Skip to content

Intracranial Pressure During Migraine

Measure of Intracranial Pressure Variations During Migraine Attacks

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03152305
Acronym
MigICP
Enrollment
60
Registered
2017-05-15
Start date
2014-07-21
Completion date
2018-07-31
Last updated
2017-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menstrual Migraine

Keywords

Migraine, Intracranial pressure, Headache

Brief summary

An increase in intracranial pressure (ICP) during migraine attacks is possible and could contribute to pain initiation and maintenance. From now on, it was not possible to measure ICP in a non-invasive way. The development of a new tool allows non-invasive self-measures of ICP variations. Thus, it is possible for the first time to look for such ICP variations during migraine attacks and to conclude if this mechanism is implied in the pathophysiology of migraine.

Detailed description

Womens presenting with regular menstrual migraine treated with triptans will be included in the study. Self-measure of ICP will be performed outside and during menstrual migraine attacks. The potential variations will be compared to the measures done on matched healthy women outside and during menses.

Interventions

OTHERIntracranial pressure variations

Self-measure of ICP will be performed outside and during menstrual migraine attacks.

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* 18 to 50 non menopausal women * Menstrual migraine * Using a triptan as usual treatment to relieve attacks * Usual triptan efficacy although recurrence is possible

Exclusion criteria

* Disease of the ear * Intracranial hypertension * Chronic daily headache * Use of topiramate or acetazolamide * Triptans used more than 10 days/month * Analgesic drug used more than 15 days/month * Uncontrolled high blood pressure * BMI \>30 * Ongoing allergic rhinitis or flu

Design outcomes

Primary

MeasureTime frameDescription
Intracranial pressure variationsduring menstrual migraine attacksMeasured during menstrual migraine attacks compared to ICP in non-migraine days and in matched healthy women

Secondary

MeasureTime frameDescription
Relationships between ICP variations and clinical parametersduring menstrual migraine attacksAge, BMI, pain intensity, pulsating pain, allodynia, nausea, photophobia, phonophobia, dizziness, tinnitus
Relationships between ICP variations and pain reliefduring menstrual migraine attacks

Countries

France

Contacts

Primary ContactPatrick LACARIN
placarin@chu-clermontferrand.fr04 73 75 11 95
Backup ContactPierre CLAVELOU
pclavelou@chu-clermontferrand.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026